Press releases

10/05/2019 12:00
|

Quantum Genomics Announces the Publication of a New Scientific Article in the Journal Hypertension

26/04/2019 14:00
|

Quantum Genomics Announces the Publication of its Phase IIb NEW-HOPE Study Results of Firibastat in Arterial Hypertension in the Journal Circulation

17/04/2019 18:00
|

Quantum Genomics Receives First Regulatory and Ethics Approvals to Initiate Phase IIb QUORUM Study of Firibastat in Heart Failure

28/03/2019 18:00
|

Quantum Genomics Reports Full-Year 2018 Financial Results

20/03/2019 18:00
|

Quantum Genomics Announces Positive Results from New Preclinical Studies on Firibastat

25/02/2019 18:00
|

Quantum Genomics Completes Enrollment in Its Pharmacokinetic Clinical Study of Firibastat

06/02/2019 18:00
|

Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure

31/01/2019 18:45
|

Quantum Genomics Presents its 2019 Corporate Action Plan

23/01/2019 18:00
|

The Association of Black Cardiologists and the Heart Institute of the Caribbean Conclude Successful First Annual Joint "Masters of Cardiology" Conference in Kingston, Jamaica

17/01/2019 18:00
|

Quantum Genomics Appoints Steering Committee for its Phase III Pivotal Trial in Resistant Hypertension